[Sendai virus vector: vector development and its application to health care and biotechnology].
Sendai virus (SeV) is an enveloped virus with a nonsegmented negative-strand RNA genome and a member of the paramyxovirus family. We have developed SeV vector which has shown a high efficiently of gene transfer and expression of foreign genes to a wide range of dividing and non-dividing mammalian cells and tissues. One of the characteristics of the vector is that the genome is located exclusively in the cytoplasm of infected cells and does not go through a DNA phase; thus there is no concern about unwanted integration of foreign sequences into chromosomal DNA. Therefore, this new class of "cytoplasmic RNA vector", an RNA vector with cytoplasmic expression, is expected to be a safer and more efficient viral vector than existing vectors for application to human therapy in various fields including gene therapy and vaccination. In this review, I describe development of Sendai virus vector, its application in the field of biotechnology and clinical application aiming to treat for a large number of diseases including cancer, cardiovascular disease, infectious diseases and neurologic disorders.
DNAVEC Corporation, 1-25-11 Kannondai, Tsukuba, Ibaraki 305-0856, Japan. iida@dnavec-corp.com
Akihiro
A
Iida
D000818:Animals; D001709:Biotechnology; D002318:Cardiovascular Diseases / Q000628:therapy; D003141:Communicable Diseases / Q000628:therapy; D003593:Cytoplasm; D015316:Genetic Therapy; D005822:Genetic Vectors; D016679:Genome, Viral; D006801:Humans; D009369:Neoplasms / Q000628:therapy; D009422:Nervous System Diseases / Q000628:therapy; D012313:RNA; D029082:Sendai virus / Q000235:genetics; D014612:Vaccines
D014612:Vaccines; D012313:RNA